Agilon Health (AGL) reported Tuesday a Q4 net loss from continuing operations of $0.26 per share, narrowing from a loss of $0.41 a year earlier.

Analysts polled by FactSet expected a loss of $0.24.

Revenue for the quarter ended Dec. 31 was $1.52 billion, up from $1.06 billion a year earlier.

Analysts surveyed by FactSet expected $1.52 billion.

For Q1, the company expects revenue of $1.48 billion to $1.52 billion. Analysts polled by FactSet expect $1.61 billion.

For 2025, Agilon expects revenue of $5.83 billion to $6.03 billion. Analysts surveyed by FactSet expect $6.41 billion.

The company's share price fell more than 15% in Wednesday premarket activity.